W. Qu
Impact in
- Clinical Biochemistry top 1%
- Advanced Glycation End Products research
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Natural Antidiabetic Agents Studies
Papers in
-
- Advanced Glycation End Products research 3
-
- Epigenetics and DNA Methylation 1
- S100 Proteins and Annexins 1
- Co-authors
- Ann Marie Schmidt (2 shared papers)Salvador Moncada (1 shared paper)Selim Cellek (1 shared paper)J Monteiro (1 shared paper)George Moxley (1 shared paper)Yan Lü (1 shared paper)Peter K. Gregersen (1 shared paper)Silviu Itescu (1 shared paper)
- Journals
- Genes and Immunity (1 paper)Journal of Surgical Research (1 paper)Diabetes & Metabolism (1 paper)American Journal of Epidemiology (1 paper)Diabetologia (1 paper)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
W. Qu
5 papers receiving 428 citations
Peers
Comparison fields: 5 of 62
- Clinical Biochemistry 266
- Endocrinology, Diabetes and Metabolism 80
- Gastroenterology 24
- Immunology 65
- Physiology 64
Countries citing papers authored by W. Qu
This map shows the geographic impact of W. Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Qu more than expected).
Fields of papers citing papers by W. Qu
This network shows the impact of papers produced by W. Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Qu. The network helps show where W. Qu may publish in the future.
Co-authors
The 25 scholars most cited alongside W. Qu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 327 | |
| 2 | 2004 | 95 | |
| 3 | 2014 | 8 | |
| 4 | 2025 | 2 | |
| 5 | 2003 | 1 | |
| 6 | 2024 | 0 |
About W. Qu
W. Qu is a scholar working on Clinical Biochemistry, Molecular Biology, Nephrology, Cardiology and Cardiovascular Medicine and Epidemiology, having authored 6 papers that have together received 433 indexed citations. Recurring topics across this work include Advanced Glycation End Products research (3 papers), Cardiovascular Health and Risk Factors (1 paper), Epigenetics and DNA Methylation (1 paper), S100 Proteins and Annexins (1 paper), Chronic Kidney Disease and Diabetes (1 paper), Asthma and respiratory diseases (1 paper), Global Public Health Policies and Epidemiology (1 paper) and Acute Myocardial Infarction Research (1 paper). The work is most often cited by research in Clinical Biochemistry (266 citations), Endocrinology, Diabetes and Metabolism (80 citations), Gastroenterology (24 citations), Immunology (65 citations) and Physiology (64 citations). W. Qu has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Ann Marie Schmidt, Salvador Moncada, Selim Cellek, J Monteiro, George Moxley, Yan Lü, Peter K. Gregersen, Silviu Itescu, D Stern and Evanthia Lalla. Their work appears in journals such as Genes and Immunity, Journal of Surgical Research, Diabetes & Metabolism, American Journal of Epidemiology and Diabetologia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.